Purdue

Law Scholar Anthony Casey’s Insights Crucial in Major Supreme Court Decision on Purdue Pharma Settlement

by

Chicago — In a landmark case, the U.S. Supreme Court recently ruled on a highly contentious bankruptcy settlement involving Purdue Pharma L.P., the maker of OxyContin, and its $6 billion proposal intended to resolve lawsuits spurred by the opioid crisis. At the heart of this legal battle was a key paragraph in the Bankruptcy Code, pivotal in determining how the courts could use bankruptcy to address mass-tort claims both swiftly and equitably. Purdue Pharma, under the ownership of the Sackler family, touched off a legal and moral storm with a proposal that included a condition … Read more

Judge McMahon Reviews Appeal Regarding Extension of Injunction in Purdue Case Impacting Sacklers and Associated Parties

by

In a notable development in Purdue’s ongoing legal saga, a recent bid was made to Judge McMahon regarding the extension of a preliminary injunction by the bankruptcy court. This injunction’s purpose is dual: firstly, to halt government actions that enforce regulatory or police powers; secondly, to freeze litigations against connected Sacklers and other nondebtor defendants. This strategic legal maneuver aims to protect the estate’s assets, which are intimately tied to the bankruptcy proceedings. The rationale behind the issuance of such an injunction is rooted in the desire to maintain the estate’s resources without external interference. … Read more

Supreme Court to Deliver Landmark Ruling in Purdue Pharma Bankruptcy, A Potent Closure to an Opioid Saga

by

Washington, D.C. — The United States Supreme Court is poised to deliver its decision on the bankruptcy case of Purdue Pharma LP, marking a significant milestone in the ongoing battle against the opioid epidemic, a crisis responsible for over 750,000 deaths between 1999 and 2022. This forthcoming opinion is expected to address numerous legal and ethical issues surrounding one of the most notorious pharmaceutical giants in recent history. Purdue Pharma, widely criticized for its role in the opioid crisis, sought bankruptcy protection to manage the wave of lawsuits alleging it aggressively marketed OxyContin despite knowing … Read more

Supreme Court’s Decision on Purdue Pharma Sets Potential Precedent for Future Mass Tort Settlements

by

Washington, D.C. – A recent Supreme Court decision affirming the opioid settlement by Purdue Pharma could set significant precedents for how similar mass tort cases are resolved in the future. The ruling, which supports the pharmaceutical giant’s plan to restructure under bankruptcy protection, encompasses a multi-billion dollar agreement pivotal for communities affected by the opioid epidemic. The contentious approval by the Supreme Court has confirmed Purdue Pharma’s settlement plan, estimated at over $10 billion, which aims to mitigate the public health crisis tied to opioids. This decision not only impacts those directly involved in the … Read more